Retail investors' access to information could take a hit at a time when they are more important than ever in financial ...
South Korean stocks rallied on Thursday, pushing the benchmark Kospi into a technical bull market. The rebound in South Korean stocks could have further to run as strength returns to the country's ...
Japan has enough cash at its disposal for a couple more rounds of yen-buying on the scale of last month's intervention, Goldman Sachs said. Whether Tokyo pulls the trigger again hinges on the rate ...
The U.S. budget deficit has surged to its highest monthly level in more than five years, with the July shortfall of $432.3 billion being the largest monthly deficit since March 2021. Norway reported a ...
Traffic is about 90% lower than the daily average of 130 ships that transited Hormuz before the U.S. and Israel attacked Iran ...
Trump officials may be considering a tax break for homeowners selling their primary residence in the lead up to the midterm ...
Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Standard Chartered last week announced plans to launch its Signature CIO funds from India’s GIFT City, located in Modi’s home state of Gujarat.
Producer prices in Japan climbed 7.2% in July. On a month-on-month basis, the PPI was only marginally up. Electricity prices were the largest contributor to the PPI on month-on-month basis. In this ...
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here's what CNBC TV's ...
Monday - Friday, 6:00 - 7:00 PM ET Novo Nordisk CEO Mike Doustdar defended the drugmaker's decision to sue rival Eli Lilly over its weight-loss drug advertising. "I am a big fan of competition. I ...
Stock futures were little changed on Wednesday nights as traders awaited more inflation data and weighed fresh earnings reports. Dow Jones Industrial Average futures traded just over the flatline. S&P ...
Novo Nordisk President and CEO Mike Doustdar joins 'Mad Money' host Jim Cramer to talk quarterly results, launching its GLP-q pill, competition in the weight-loss drug space, and more. Got a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results